Tarek Hammoud - Oct 25, 2021 Form 4/A - restatement Insider Report for Enfusion, Inc. (ENFN)

Role
Director, 10%+ Owner
Signature
/s/ Blake Nielsen, as Attorney-in-Fact for Tarek Hammoud
Stock symbol
ENFN
Transactions as of
Oct 25, 2021
Transactions value $
-$24,569,633
Form type
4/A - RESTATEMENT
Date filed
4/26/2022, 08:57 PM
Date Of Original Report
Oct 26, 2021
Previous filing
Apr 26, 2022
Next filing
Oct 19, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ENFN Common Units of Enfusion Ltd. LLC Disposed to Issuer -$24.6 M -1.55 M -11.52% $15.90 11.9 M Oct 25, 2021 Class A Common Stock 1.55 M See Footnote F1, F2, F3

Explanation of Responses:

Id Content
F1 The common units of Enfusion Ltd. LLC (the "Common Units"), and the corresponding shares of Class B common stock are exchangeable for shares of the Issuer's Class A common stock on a one-for-one basis with the Issuer having the ability to elect to pay cash in lieu of issuing Class A common stock.
F2 This amount represents the $17.00 initial public offering price per share of common stock of the Issuer, less the underwriting discount of $1.105 per share.
F3 These Common Units are held by LRA Ventures, LLC. Tarek Hammoud is the sole manager of LRA Ventures, LLC, an estate planning vehicle of which Mr. Hammoud is the sole manager. Mr. Hammoud may be deemed to have dispositive power over the Common Units held by LRA Ventures, LLC. Mr. Hammoud disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein.

Remarks:

This amendment to Form 4 filed on 10/26/2021 is being filed to include LRA Ventures, LLC as a Reporting Person.